These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36872357)

  • 1. Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders.
    Srivastava P; Sudevan ST; Thennavan A; Mathew B; Kanthlal SK
    CNS Neurol Disord Drug Targets; 2024; 23(3):331-341. PubMed ID: 36872357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease.
    Deshwal S; Di Sante M; Di Lisa F; Kaludercic N
    Curr Opin Pharmacol; 2017 Apr; 33():64-69. PubMed ID: 28528298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inactivation: from pathophysiology to therapeutics.
    Bortolato M; Chen K; Shih JC
    Adv Drug Deliv Rev; 2008; 60(13-14):1527-33. PubMed ID: 18652859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.
    Duarte P; Cuadrado A; León R
    Handb Exp Pharmacol; 2021; 264():229-259. PubMed ID: 32852645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies.
    Rehuman NA; Mathew B; Jat RK; Nicolotti O; Kim H
    Comb Chem High Throughput Screen; 2020; 23(9):898-914. PubMed ID: 32342809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidases in development.
    Wang CC; Billett E; Borchert A; Kuhn H; Ufer C
    Cell Mol Life Sci; 2013 Feb; 70(4):599-630. PubMed ID: 22782111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs related to monoamine oxidase activity.
    Fišar Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():112-24. PubMed ID: 26944656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.
    Manzoor S; Hoda N
    Eur J Med Chem; 2020 Nov; 206():112787. PubMed ID: 32942081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.
    Aljanabi R; Alsous L; Sabbah DA; Gul HI; Gul M; Bardaweel SK
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor design for monoamine oxidases.
    Ramsay RR
    Curr Pharm Des; 2013; 19(14):2529-39. PubMed ID: 23116392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of monoamine oxidase inhibitors in chronic neurodegeneration.
    Riederer P; Müller T
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
    Naoi M; Riederer P; Maruyama W
    J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidases as sources of oxidants in the heart.
    Kaludercic N; Mialet-Perez J; Paolocci N; Parini A; Di Lisa F
    J Mol Cell Cardiol; 2014 Aug; 73():34-42. PubMed ID: 24412580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine Oxidase-Related Vascular Oxidative Stress in Diseases Associated with Inflammatory Burden.
    Sturza A; Popoiu CM; Ionică M; Duicu OM; Olariu S; Muntean DM; Boia ES
    Oxid Med Cell Longev; 2019; 2019():8954201. PubMed ID: 31178977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases.
    Hassan AHE; Kim HJ; Gee MS; Park JH; Jeon HR; Lee CJ; Choi Y; Moon S; Lee D; Lee JK; Park KD; Lee YS
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):768-780. PubMed ID: 35196956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
    Shetnev A; Osipyan A; Baykov S; Sapegin A; Chirkova Z; Korsakov M; Petzer A; Engelbrecht I; Petzer JP
    Bioorg Med Chem Lett; 2019 Jan; 29(1):40-46. PubMed ID: 30455149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.
    Naoi M; Maruyama W; Inaba-Hasegawa K
    Curr Top Med Chem; 2012; 12(20):2177-88. PubMed ID: 23231395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoamine oxidase as a target for drug action].
    Drozak J; Kozłowski M
    Postepy Hig Med Dosw (Online); 2006; 60():498-515. PubMed ID: 17060892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes.
    Sturza A; Duicu OM; Vaduva A; Dănilă MD; Noveanu L; Varró A; Muntean DM
    Can J Physiol Pharmacol; 2015 Jul; 93(7):555-61. PubMed ID: 25996256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update.
    Tripathi RKP; Ayyannan SR
    Med Res Rev; 2019 Sep; 39(5):1603-1706. PubMed ID: 30604512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.